Don’t Just COPE with COPD:
The ENDURA Research Studies

Now assessing an investigational medicine that targets inflammation.

These research studies are looking to enroll adults aged 40 to 80 who are current/former smokers with COPD – see if you
(or a loved one) may qualify!
COPD = Chronic Obstructive Pulmonary Disease

Don’t Just COPE with COPD: The ENDURA Research Studies

Now assessing an investigational medicine that targets inflammation.

These research studies are looking to enroll adults aged 40 to 80 who are current/former smokers with COPD – see if you (or a loved one) may qualify!
COPD = Chronic Obstructive Pulmonary Disease

Those who qualify and enroll may receive*:

Reimbursement
for travel to and from the study site.

Compensation
for their time.

Study drug

These studies also offer study-related pulmonary monitoring by lung specialists – at no cost to you. And, if your country laws permit, a third party contracted by GSK may be used to support reimbursement and travel arrangements.

Take the next step to see if you may qualify for an ENDURA research study.

About COPD and the ENDURA Studies

COPD is a broad term that comprises several chronic (on-going) lung conditions such as chronic bronchitis* and emphysema**. Key signs and symptoms may include difficulty breathing/shortness of breath, wheezing, tiredness, and a chronic cough (with or without mucus). Symptoms may get worse at times, called “exacerbations.” These flare-ups may do further damage to the lungs, so it’s important to effectively treat COPD.

*Chronic bronchitis is due to damage to bronchial tubes. They become irritated and swollen resulting in coughing and shortness of breath. If there is mucus with the cough for at least several months, it’s considered “chronic” bronchitis.

**Emphysema is when the air sacs in the lungs become damaged and can no longer do a good job of taking the oxygen you breathe into your blood for other organs to use.

Though there is no cure for COPD, medications exist to help make breathing easier. Even so, more targeted treatments are needed and studies like this one are how we develop them.

The purpose of the ENDURA studies is to see if the investigational medicine can reduce the number of COPD flare-ups, called exacerbations, and help improve quality of life in people with the condition.

The ENDURA studies are each assessing the same investigational medication — a type of biologic medicine given as an injection under the skin — for the treatment of moderate to severe COPD. “Biologic” simply means that it is derived from a living thing (like cells) as opposed to being a synthetic chemical.

By “investigational,” we mean that it has not been approved for use by the general public but is currently being evaluated in these studies.

Total participation in the study will vary but will last about 1 to 2 years. Know that you can withdraw from a study at any time and for any reason.

Act now to see if you may qualify for an ENDURA study.

How does it work?

Answer
some questions about your health

Tell
us a little bit about you

Connect
with us

Just takes a few minutes.

AcurianHealth helps connect people with research studies. Since 1998, AcurianHealth has referred over 1 million study candidates to 800 research studies all over the world.
Terms of Use | Privacy Policy
©2025 Acurian, Inc. All rights reserved.
*In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. For studies that offer compensation, reasonable payments will be made for participation. The length of the study may vary.